Tag: Indian Immunologicals
Indian Immunologicals’ subsidiary in New Zealand lives up to its promise
From humble beginnings as a backward integration project, Pristine Biologicals has grown into as a self-sustainable unit and consistent supplier of quality raw materials.
Indian Immunologicals unveils India’s first gE-deleted DIVA marker vaccine for IBR
Millions of livestock and farmers are expected to be benefited from this vaccine
World Zoonosis Day 2025: Indian Immunologicals administers 1 lakh free dosages...
Nationwide vaccination camps at around 100 cities across 21 states
Indian Immunologicals holds scientific conclave on pandemic preparedness & vaccine innovation
The objective of this conclave was to ideate, explore and collaborate on the learnings of the pandemic, and to build a more robust & resilient health care system
Indian Immunologicals develops first-of-its kind needle-free COVID-19 intranasal vaccine
IIL in partnership with Griffith University, Australia developed needle free intra-nasal booster vaccine against SARS-CoV-2 using codon deoptimization technology
Dr K Anand Kumar receives prestigious ‘Vocational Excellence Award 2023-24’
As the Managing Director of Indian Immunologicals, Dr. Kumar channeled efforts to repurpose vaccine manufacturing facility during the COVID-19 pandemic and rolled out COVID-19 vaccine drug substance quickly
Indian Immunologicals to construct greenfield animal vaccine manufacturing facility in Hyderabad
Groundbreaking ceremony of IIL's Greenfield Animal Vaccine Manufacturing Facility held at Genome Valley, Hyderabad
Indian Immunologicals celebrates 25 years of Human Biologicals Institute
The company also launched live attenuated MR vaccine in an exclusive partnership with Polyvac Institute, Vietnam
Indian Immunologicals launches Measles & Rubella vaccine
This live attenuated MR vaccine has been developed by IIL in an exclusive partnership with Polyvac Institute, Vietnam
Indian Immunologicals receives regulatory approval for Measles-Rubella vaccine
This vaccine has been proven through extensive human clinical trials to be immunogenic and safe for people of 9 months to 49 years